Clinical trial
Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation
NCT00419731 · University of Minnesota, Other · Unknown status
Key facts
| NCT number | NCT00419731 |
|---|---|
| Title | Study of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation |
| Official title | Phase II Randomized, Double-Blind Trial of Bupropion Versus Bupropion + Naltrexone for Smoking Cessation |
| Lead sponsor | University of Minnesota, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Unknown status |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Tobacco Use Disorder |
| Intervention type | Drug |
| Interventions | Bupropion, Bupropion + Naltrexone |
| Enrollment | 120 |
| Start date | Nov 1, 2006 |
| Primary completion | Feb 1, 2010 |
| Completion | Jul 1, 2010 |
| First posted | Jan 9, 2007 |
| Last update posted | Dec 3, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: